Literature DB >> 29533134

The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice.

Xiao-Zhen Kang1,2, Xue-Ran Guo1,2, Bin-Bing Chen1,2, Tian-Ying Zhang1,2, Quan Yuan1,2, Pei-Jer Chen3, Jun Zhang1,2, Ning-Shao Xia1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29533134      PMCID： PMC6067855          DOI： 10.1080/21645515.2018.1449553

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  9 in total

1.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Authors:  Chien-Jen Chen; Hwai-I Yang; Jun Su; Chin-Lan Jen; San-Lin You; Sheng-Nan Lu; Guan-Tarn Huang; Uchenna H Iloeje
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

2.  Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.

Authors:  Tai-Chung Tseng; Chun-Jen Liu; Chi-Ling Chen; Hung-Chih Yang; Tung-Hung Su; Chia-Chi Wang; Wan-Ting Yang; Stephanie Fang-Tzu Kuo; Chen-Hua Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  J Infect Dis       Date:  2013-05-08       Impact factor: 5.226

Review 3.  Pathogenesis of hepatitis B virus infection.

Authors:  F V Chisari; M Isogawa; S F Wieland
Journal:  Pathol Biol (Paris)       Date:  2010-02-08

4.  Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.

Authors:  Tian-Ying Zhang; Quan Yuan; Jing-Hua Zhao; Ya-Li Zhang; Lun-Zhi Yuan; Ying Lan; Yu-Chieh Lo; Cheng-Pu Sun; Chang-Ru Wu; Jun-Fang Zhang; Ying Zhang; Jia-Li Cao; Xue-Ran Guo; Xuan Liu; Xiao-Bing Mo; Wen-Xin Luo; Tong Cheng; Yi-Xin Chen; Mi-Hua Tao; James Wk Shih; Qin-Jian Zhao; Jun Zhang; Pei-Jer Chen; Y Adam Yuan; Ning-Shao Xia
Journal:  Gut       Date:  2015-09-30       Impact factor: 23.059

5.  Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice.

Authors:  Yanyan Zheng; Wen-ling Chen; Stan G Louie; T S Benedict Yen; Jing-hsiung James Ou
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

6.  Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice.

Authors:  S N Huang; F V Chisari
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

7.  Hepatitis B virus infection.

Authors:  Yun-Fan Liaw; Chia-Ming Chu
Journal:  Lancet       Date:  2009-02-14       Impact factor: 79.321

Review 8.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Authors:  Aparna Schweitzer; Johannes Horn; Rafael T Mikolajczyk; Gérard Krause; Jördis J Ott
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

9.  Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies.

Authors:  Yannick Bulliard; Rose Jolicoeur; Maurice Windman; Sarah M Rue; Seth Ettenberg; Deborah A Knee; Nicholas S Wilson; Glenn Dranoff; Jennifer L Brogdon
Journal:  J Exp Med       Date:  2013-07-29       Impact factor: 14.307
  9 in total
  1 in total

1.  A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice.

Authors:  Tian-Ying Zhang; Xue-Ran Guo; Yang-Tao Wu; Xiao-Zhen Kang; Qing-Bing Zheng; Ruo-Yao Qi; Bin-Bing Chen; Ying Lan; Min Wei; Shao-Juan Wang; Hua-Long Xiong; Jia-Li Cao; Bao-Hui Zhang; Xiao-Yang Qiao; Xiao-Fen Huang; Ying-Bin Wang; Mu-Jin Fang; Ya-Li Zhang; Tong Cheng; Yi-Xin Chen; Qin-Jian Zhao; Shao-Wei Li; Sheng-Xiang Ge; Pei-Jer Chen; Jun Zhang; Quan Yuan; Ning-Shao Xia
Journal:  Gut       Date:  2019-03-29       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.